Bull,S.B., Ozcelik, H., Pinnaduwage, D., Blackstein, M.E., Sutherland, D., Pritchard K.I., Tzontcheva A., Sidlofsky, S., Hanna, W., Qizilbash, M.D., Tweeddale, M., Fine, S., McCready, D., Andrulis, I.L. (2004) The Combination of p53 Mutation and neu/erbB-2 Amplification is Associated with Increased Risk of Recurrence in Node-Negative Breast Cancer. J. Clin. Oncol. 22: 86-96.
John, E.M., Hopper, J.L., Beck, J.C., Knight, J.A., Neuhausen, S.L., Senie, R.T., Ziogas, A., Andrulis, I.L., Anton-Culver, H., Boyd, N., Buys, S., Daly, M.B., Santella, R.M., Southey, M.C., Venne, V., Venter, D.J., West, D., Whittemore, A.S., and Seminara, D. and the Breast Cancer Family Registry. (2004) The Breast Cancer Family Registry (Breast CFR): An Infrastructure for Co-operative Multinational, Interdisciplinary and Translational Studies of the Genetic Epidemiology of Breast Cancer. Breast Cancer Res. 6: R375-R389.
Wunder, J.S., Gokgoz, N., Parkes, R., Bull, S.B., Eskandarian, S., Davis, A.M., Beauchamp, C.P., Conrad, E.U., Grimer, R.J., Healey, J.H., Malkin, D., Mangham, D.C., Rock, M.J., Bell, R.S., and Andrulis, I.L. (2005) TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study. J Clin. Oncol. 23:1483-1490.
Pritchard K.I., Shepherd L.E., O’Malley F.P., Andrulis I.L., Tu D., and Levine M.N. for the National Cancer Institute of Canada Clinical Trials Group. (2006) Neu/ErbB2 and responsiveness of breast cancer to adjuvant chemotherapy. New England Journal of Medicine 354:2103-2111.
Bane, A.L., Beck, J.C., Bleiweiss, I., .. Andrulis, I.L., O’Malley, F.P. for the BCFR (2007) BRCA2 Mutation-Associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles from Tissue Microarrays. Am J Surg Pathol. 31:121-128.
Reedijk, M., Pinnaduwage, D., Dickson, B.C., Mulligan, A.M., Zhang, H., Bull, S.B., O’Malley, F.P., Egan, S. E., and Andrulis, I.L. (2008) Elevated JAG1 mRNA expression, associated with the basal phenotype, is a poor-prognosis indicator in lymph node-negative breast cancer. Breast Cancer Res Treat. 111:439-448.
Mulligan, A.M., Pinnaduwage, D., Bull, S.B., O’Malley, F.P., and Andrulis, I.L. (2008) The prognostic impact of basal-like breast cancers is time dependent: evidence from Tissue Microarray studies on a lymph node negative cohort. Clin. Cancer Res. 14: 4168-4174
O’Malley, F.P., Chia, S., Tu, D., Shepherd, L.E., Levine, M.N., Bramwell, V.H., Andrulis, I.L., and Pritchard, K.I. (2009) Topoisomerase II alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy. J Natl. Cancer Inst 101:644-650.
Viloria-Petit, A.M., Erdemir, T., Bane, A., Pinnaduwage, D., Roncari, R., Bose, L., Narimatsu, M., Wong, J., Kerbel, R.S., O’Malley, F.P., Andrulis, I.L., and Wrana, J. (2009) The TGFβ-Par6 Polarity Pathway Controls Breast Cancer Invasion and Metastasis. Proc Natl Acad Sci USA. 106:14028-14033.
Ponzo, M.G., Lesurf, R., Petkiewicz, S., O’Malley, F.P., Pinnaduwage, D., Andrulis, I.L., Bull, S.B., Chughtai, N., Germain, D., Omeroglu, A., Cardiff, R.D., Hallett, M., and Park, M. (2009) Met induces mammary tumors with multiple pathologies and is associated with both poor outcome and basal-type breast cancers. Proc Natl Acad Sci USA 106:12903-12908.
Mulligan, A.M., Pinnaduwage, D., Bane, A.L., Bull, S.B., O’Malley, F.P., and Andrulis, I.L. (2011) CK8/18 expression, the basal phenotype and family history in identifying BRCA1-associated breast cancer in the Ontario site of the Breast Cancer Family Registry. Cancer 117: 1350-1359.
Asimit, J.L., Andrulis, I.L. and Bull, S.B. (2011) A scan statistic for identifying chromosomal regions of association between gene expression and copy number. Statistics in Medicine. 30:1157-1178.
Bane, A. L., Pinnaduwage, D., Weerasooriya, N, O'Malley, F.P. and Andrulis, I.L. (2011) EMSY & CCND1 Amplification in Familial Breast Cancer: From the Ontario Site of the Breast Cancer Family Registry. Breast Cancer Research and Treatment 127:831-839.
O’Malley, F.P., Chia, S.,Tu, D., Shepherd, L.E. Levine, M.N., Huntsman, D., Bramwell, V.H., Andrulis, I.L., and Pritchard, K.I. (2011) Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial. Breast Cancer Research and Treatment. 128:401-409.
Kurian, A.W., Gong, G.D., John, E.M., Johnston, D.A., Felberg, A., West, D.W., Miron, A., Andrulis, I.l., Hopper, J.L., Knight, J. A., Ozcelik, H., Dite, G.S., Apicella, C., Southey, M.C., and Whittemore, A.S. (2011) Breast Cancer Risk for Non-Carriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings from the Breast Cancer Family Registry. J Clin Oncol. 29:4505-4509.
Zhang, R.L, Chiarelli, A.M., Glendon, G., Mirea, L., Knight, J.A., Andrulis, I.L., Ritvo P. (2011) Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario Site of the Breast Cancer Family Registry. European Journal of Cancer Prevention 20:255-262.
Mulligan, A.M., Couch, F.J., Barrowdale, D., Domchek, S.M., Eccles, D., Nevanlinna, H., Ramus, S.J., Robson, M., Sherman, M. Spurdle, A.B., Wappenschmidt, B., Lee, A., McGuffog, L., Healey, S., Sinilnikova, O.M., Janavicius, R., Hansen, T.v.O., Nielsen, F.C., Ejlertsen, B., Osorio, A., Muñoz-Repeto, I., Durán, M., Godino, J., Pertesi, M., Benítez, J., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Cattaneo, E., Bonanni, B., Viel, A., Pasini, B., Papi, L., Ottini, L., Savarese, A., Bernard, L., Radice, P., Hamann, U., Verheus, M., Meijers-Heijboer, H.E.J., Wijnen, J., Gómez García, E.B., Nelen, M. R., Kets, M., Seynaeve, C., Tilanus-Linthorst, M.M.A., van der Luijt, R.B., van Os, T., Rookus, M., HEBON, Frost, D., Jones, J.L., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Adlard, J., Davidson, R., Cook, J., Donaldson, A., Dorkins, H., Gregory, H., Eason, J., Houghton, C., Barwell, J., Side, L.E., McCann, E., Murray, A., Peock, S., EMBRACE, Godwin, A., Schmutzler, R.K., Rhiem, K., Engel, C., Meindl, A., Ruehl, I., Arnold, N., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Kast, K., Preisler-Adams, S., Varon-Mateeva, R., Schoenbuchner, I., Fiebig, B., Heinritz, W., Schäfer, D., Gevensleben, H., Caux-Moncoutier, V., Fassy-Colcombet, M., Cornelis, F., Mazoyer, S., Léoné, M., Boutry-Kryza, N., Hardouin, A., Berthet, P., Muller, D., Fricker, J-P., Mortemousque, I., Pujol, P., Coupier, I., Lebrun, M., Kientz, C., Longy, M., Sevenet, N., Stoppa-Lyonnet, D., GEMO, Isaacs, C., Caldes, T., de la Hoya, M., Heikkinen, T., Aittomäki, K., Blanco, I., Lazaro, C., Barkardottir, R.B., Soucy, P., Dumont, M., Simard, J., Montagna, M., Tognazzo, S., D’Andrea, E., Fox, S., Yan, M., kConFab, Rebbeck, T., Olopade, O.I., Weitzel, J.N., Lynch, H.T., Ganz, P.A., Tomlinson, G.E., Wang, X., Fredericksen, Z., Pankratz, V.S., Lindor, N.M., Szabo, C., Offit, K., Sakr, R., Gaudet, M., Bhatia, J., Kauff, N., Singer, C.F., Tea, M-K., Geschwantler-Kaulich, D., Fink-Retter, A., Mai, P.L., Greene, M.H., Imyanitov, E., O'Malley, F.P., Ozcelik, H., Glendon, G., OCGN, Toland, A.E., Gerdes, A-M., Thomassen, M., Kruse, T.A., Jensen, U.B., Skytte, A-B., Caligo, M.A., Soller, M., Henriksson, K., von Wachenfeldt, A., Arver, B., Stenmark-Askmalm, M., Karlsson, P., SWE-BRCA, Chun Ding, Y., Neuhausen, S.L., Beattie, M., Pharoah, P.D.P., Moysich, K.P., Nathanson, K.L., Karlan, B.Y., Gross, J., John, E.M., Daly, M.J., Buys, S.M., Southey, M.C., Hopper, J.L., Terry, M.B., Chung, W., Miron, A.F., Goldgar, D., BCFR, Chenevix-Trench, G., Easton, D.F., Andrulis, I.L., and Antoniou, A.C. (2011) Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res.13(6):R110.
Greenwood, C.M.T., Paterson, A.D., Linton, L., Andrulis, I.L., Apicella, C., Dimitromanolakis, A., Kriukov, V., Martin, L.J., Salleh, A., Samiltchuk, E., Satariano, E., Southey, M.C., John, E.M., Hopper, J.L., Boyd, N.F., and Rommens, J.M. A genome-wide linkage study of mammographic density, a risk factor for breast cancer, using B-CFR and collected families. (2011) Breast Cancer Res. 13(6):R132.
Ghoussaini, M., Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M.K., Dicks, E., Dennis, J., Wang, Q., Humphreys, M.K., Luccarini, C., Baynes, C., Conroy, D., Maranian, M., Ahmed, S., Driver, K., Johnson, N., Orr, N., dos Santos Silva, I., Waisfisz, Q., Meijers-Heijboer, H., Uitterlinden, A,G., Rivadeneira, F., HEBON, Hall, P., Czene, K., Irwanto, A., Liu, J., Nevanlinna, H., Aittomäki, K., Blomqvist, C., Meindl, A., Schmutzler, R.K., Müller-Myhsok, B., Chang-Claude, J., Hein, R., Nickels, S., Flesch-Janys, D., Tsimiklis, H., Makalic, E., Schmidt, D., Bui, M., Hopper, J.L., Apicella, C., Park, D.J., Southey, M., Hunter, D.J., Chanock, S.J., Broeks, A., Verhoef, S., Hogervorst, F.B.l., Fasching, P.A., Sawyer, E., Tomlinson, I., Kerin, M., Marme, F., Schneeweiss, A., Sohn, C., Burwinkel, B., Guénel, P., Truong, T., Cordina-Duverger, E., Menegaux, F., Bojesen, S.E., Nordestgaard, B.G., Nielsen, S.F., Flyger, H., Milne, R.L., Alonso, R., González-Neira, A., Benítez, J., Anton-Culver, H., Ziogas, A., Bernstein, L., Clarke Dur, C., Brenner, H., Müller, H., Arndt, V., Stegmaier, C., FBCS, Justenhoven, C., Brauch, H., Pesch, B., GENICA, Wang-Gohrke, S., Eilber, U., Dörk, T., Schürmann, P., Bremer, M., Hillemanns, P., Bogdanova, N.V., Antonenkova, N.N., Rogov, Y.I., Karstens, J.H., Bermisheva, M., Prokofieva, D., Khusnutdinova, E., Lindblom, A., Margolin, S., Mannermaa, A., Kataja, V., Kosma, V-M., Hartikainen, J.M., Lambrechts, D., Yesilyurt, B.T., Floris, G., Leunen, K., Manoukian, S., Bonanni, B., Fortuzzi, S., Peterlongo, P., Couch, F.J., Wang, X., Stevens, K., Lee, A., Giles, G.G., Baglietto, L., Severi, G., McLean, C., Alnæs, G.G., Kristensen, V., Børrensen-Dale, A-L., John, E.M., Miron, A., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Kauppila, S., Andrulis, I.L., Glendon, G., Mulligan, A.M., Devilee, P., van Asperen, C.J., Tollenaar, R.A.E.M., Seynaeve, C., Figueroa, J.D., Garcia-Closas, M., Brinton, L., Lissowska, J., Hooning, M.J., Hollestelle, A., Oldenburg, R.A., van den Ouweland, A.M.W., Cox, A., Reed, M.W.R., Shah, M., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Jones, M., Schoemaker, M., Ashworth, A., Swerdlow, A., Beesley, J., Chen, X., kConFab, AOCSG, Muir, K.R., Lophatananon, A., Rattanamongkongul, S., Chaiwerawattana, A., Kang, D., Yoo, K-Y., Noh, D-Y., Shen, C-Y., Yu, Y-C., Wu, P-E., Hsiung, C.N., Perkins, A., Swann, R., Velentzis, L., Eccles, D.M., Tapper, W.J., Gerty, S.M., Graham, N.J., Ponder, B.A.J., Chenevix-Trench, G., Pharoah, P.D.P., Lathrop, M., Dunning, A.M., Rahman, N., Peto, J., and Easton, D.F. (2012) Genome-wide association analyses identifies three new breast cancer susceptibility loci. Nature Genetics. 44:312-318.
Bolton, K.L., Chenevix-Trench, G., Goh, C., Sadetzki, S., Ramus, S.J., Lambrechts, D., Despierre, E., Barrowdale, D., McGuffog, L., Healey, S., Easton, D.F., Sinilnikova, O., Benitez, J., García, M.J., Neuhausen, S., Gail, M.H., Hartge, P., EMBRACE, Peock, S., Frost, D., Evans, D.G., Eeles, R., Godwin, A., Daly, M., Kwong, A., Ma, E.S.K., Lázaro, C., Blanco, I., Montagna, M., D'Andrea, E., Nicoletto, O., kConFab, Johnatty, S., Krüger Kjær, S., Jensen, A., Høgdall, E., Goode, E.L., Fridley, B.L., Loud, J.T., Greene, M.h., Mai, P.L., Chetrit, A., Lubin, F., Hirsh-Yechezkel, G., Glendon, G., Andrulis, I.L., Toland, A.E., Senter, L., Gore, M.E., Gourley, C., Michie, C.O., Song, H., Tyrer, J., Whittemore, A.S., McGuire, V., Sieh, W., Kristoffersson, U., Olsson, H., Borg, A., Levine, D.A., Cancer Genome Atlas Research Network, Steele, L., Beattie, M.S., Chan, S., Nussbaum, R., Moysich, K.B., Gross, J., Cass, I., Walsh, C., Li, A., Leuchter, R., Gordon, O., Karlan, B.Y., Garcia-Closas, M., Gayther, S.A., Chanock, S.J., Antoniou, A.C., and Pharoah, P.D.P. (2012) A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on Ovarian Cancer Survival. JAMA 307:382-390.
Park, D.J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S.L., John, E.M., Andrulis, I.L., Terry, M.B., Daly, M., Buys, S., Le Calvez-Kelm, F., Lonie, A., Pope, B.J., Tsimiklis, H., Voegele, C., Hilbers, F.M., Hoogerbrugge, N., Barroso, A., Osorio, A., BCFR, kConFab, Giles, G.G., Devilee, P., Benitez, J., Hopper, J.L., Tavtigian, S.V., Goldgar, D.E., and Southey, M.C. (2012) Rare mutations in XRCC2 confer increased risk of breast cancer. Amer J Hum Genet 90:1-6.
Goodwin, P.J., Phillips, K-A., West, D.W., Ennis, M., Hopper, J.L., John, E.M., O'Malley, F.P., Milne, R.L., Andrulis, I.L., Friedlander, M.L., Southey, M.C., Giles, G.G., Apicella, C. and Longacre, T.A. (2012) Breast cancer prognosis of BRCA1 and BRCA2 mutation carriers: an international prospective population-based cohort study. J Clin Oncol. 30:19-26.
Vachon, C.M., Scott, C.G., Fasching, P.A., Hall, P., Tamimi, R.M., Li, J., Stone, J., Apicella, C., Odefrey, F., Gierach, G.L., Jud, S.M., Heusinger, K., Beckmann, M.W., Pollan. M., Fernandez-Navarro, P., Gonzalez-Neira, A., Benítez, J., van Gils, C.H., Lokate, M.A., Onland-Moret, N.C., Peeters, P.H., Brown, J., Leyland, J., Varghese, J.S., Easton, D.F., Thompson, D.J., Luben, R.N., Warren, R.M., Wareham, N.J., Loos, R.J., Khaw, K.T., Ursin, G., Lee, E., Gayther, S.A., Ramus, S.J., Eeles, R.A., Leach, M.O., Kwan-Lim, G. For The Uk Study Of Mri Screening, Couch, F.J., Giles, G.G., Baglietto, L., Krishnan, K., Southey, M.C., Le Marchand, L., Kolonel, L.N., Woolcott, C., Maskarinec, G., Haiman, C.A., Walker, K., Johnson, N., McCormack, V.A., Biong, M., Grenaker, A.G., Torhild, G.I., Kristensen, V.N., Borresen-Dale, A.L., Lindström, S., Hankinson, S.E., Hunter, D.J., Andrulis, I.L., Knight, J.A., Boyd, N.F., Figueroa, J.D., Lissowska, J., Wesolowska, E., Peplonska, B., Bukowska, A., Reszka, E., Liu, J., Eriksson, L., Czene, K., Audley, T., Wu, A.H., Pankratz, V.S., Hopper, J.L., Dos. Santos, S.I. (2012) Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2012 Mar 27. [Epub ahead of print]
Weischer, M., Nordestgaard, B.G., Pharoah, P., Humphreys, M.K., Nevanlinna, H., van 't Veer, L.J., Garcia-Closas, M., Hopper, J.L., Hall, P., Andrulis, I.L., Devilee, P., Fasching, P.A., Anton-Culver, H.A., Lambrechts, D., Hooning, M., Cox, A., Giles, G.G., Burwinkel, B., Lindblom, A., Couch, F., Mannermaa, A., Alnæs, G.G., John, E.M., Dörk, T., Flyger, H., Dunning, A.M., Wang, Q., Muranen, T.A., van Hien, R., Figueroa, J., Southey, M.C., Czene, K., Knight, J.A., Tollenaar, R.A.E.M., Beckmann, M.W., Ziogas, A., Christiaens, M-R., Collée, J.M., Reed, M.W.R., Severi, G., Marme, F., Margolin, S., Olson, J.E., Kosma, V-M., Kristensen, V.N., Miron, A., Bogdanova, N., Shah, M., Blomqvist, C., Broeks, A., Sherman, M., Phillips, K., Li, J., Liu, J.J., Glendon, G., Seynaeve, C., Ekici, A.B., Leunen, K., Krieger, M., Cross, S.S., Baglietto, L., Sohn, C., Wang, X., Kataja, V., Børresen-Dale, A-L., Meyer, A., Easton, D.F., Schmidt, M.K., and Bojesen, S.E. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer specific death, and increased risk of a second breast cancer. J Clin Oncol (in press).
Work, M.E., Andrulis, I.L., John, E.M., Hopper, J.L., Liao, Y., Zhang, F.F., Knight, J.A., West, D.W., Milne, R.L., Giles, G.G., Longacre, T.A., O’Malley, F., Mulligan, A.M., Southey, M.C., Hibshoosh, H., Terry, M.B. (2012) Risk Factors for Uncommon Histologic Subtypes of Breast Cancer in the Breast Cancer Family Registry, Using Centralized Pathology Review. Breast Cancer Research and Treatment April 25 (Epub ahead of print).